Privia Health Group Stock (NASDAQ:PRVA)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$20.37

52W Range

$19.53 - $28.82

50D Avg

$23.62

200D Avg

$23.21

Market Cap

$2.57B

Avg Vol (3M)

$1.22M

Beta

0.88

Div Yield

-

PRVA Company Profile


Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,226

IPO Date

Apr 28, 2021

Website

PRVA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Other Revenue$9.18M$8.55M$8.50M
Shared Savings$234.81M$179.20M$170.14M
Capitated Revenue$308.46M$212.99M$338.73M
Care Management Fee (PMPM)$73.14M$64.07M$50.52M
FFS-Administrative Services$137.02M$125.43M$113.15M
FFS-Patient Care$1.36B$1.15B$976.69M

Fiscal year ends in Dec 25 | Currency in USD

PRVA Financial Summary


Dec 25Dec 24Dec 23
Revenue$2.12B$1.74B$1.66B
Operating Income$34.23M$16.98M$20.65M
Net Income$22.92B$14.38M$23.08M
EBITDA$53.84M$24.25M$27.18M
Basic EPS$0.19$0.12$0.20
Diluted EPS$0.18$0.11$0.19

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q2 26Aug 06, 26 | 8:00 AM
Q1 26May 07, 26 | 8:00 AM
Q4 25Feb 26, 26 | 8:00 AM

Peer Comparison


TickerCompany
LIVNLivaNova PLC
ATECAlphatec Holdings, Inc.
HTFLHeartflow, Inc. Common Stock
NVSTEnvista Holdings Corp
PBHPrestige Consumer Healthcare Inc.
ARQTArcutis Biotherapeutics, Inc.
TVTXTravere Therapeutics, Inc.
ICUIICU Medical, Inc.
SUPNSupernus Pharmaceuticals, Inc.